| Intrinsic Valuation of: ALKEM | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 181 | Market Cap | ₹591B | |||||
| 2021 | - | - (-) | P/E Ratio | 27 | Total Asset | ₹177B | |||||
| 2022 | ₹8B | - (-) | Net Income | ₹22B | Total Debt | ₹3B | |||||
| 2023 | ₹14B | 87.7% (72.5%) | EBITDA | ₹30B | Total Liab | ₹53B | |||||
| 2024 | ₹17B | 16.5% (5.2%) | Opr Margin | 0.17 | Debt/Equity | 0.03 | |||||
| 2025 | ₹12B | -26.7% (-28.4%) | PreTax Margin | 15.68 | BV/Share | 957 | |||||
| 5Y Average FCF | ₹13B | 25.8% (16.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | ₹15B | MBG Intrinsic Value | ₹1,618 | ||||||||
| 2027 | ₹19B | ||||||||||
| 2028 | ₹24B | ||||||||||
| 2029 | ₹30B | ||||||||||
| 2030 | ₹38B | ||||||||||
| 2031 | ₹47B | ||||||||||
| Terminal Value | ₹981B | Net Worth/Share | ₹1,040 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹769B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹3B | ₹6,429 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹3B | WACC | 7.3% | 5,590 | 6,035 | 6,574 | 7,236 | 8,072 | |||
| Equity Value | ₹769B | 7.4% | 5,537 | 5,974 | 6,500 | 7,147 | 7,961 | ||||
| Shares Outstanding | 119,565,000 | 7.4% | 5,485 | 5,913 | 6,429 | 7,060 | 7,852 | ||||
| 7.9% | 5,012 | 5,366 | 5,784 | 6,288 | 6,905 | ||||||
| DCF Intrinsic Value | ₹6,429 | 8.4% | 4,609 | 4,904 | 5,249 | 5,658 | 6,150 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||